LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 92

Search options

  1. Article ; Online: Management of pregnancy in a patient with congenital hyperinsulinism treated with association of diazoxide/calcium channel blocker.

    Lemaitre, Madleen / Douillard, Claire / Froguel, Philippe / Bonnefond, Amélie / Vambergue, Anne

    Acta diabetologica

    2022  Volume 59, Issue 8, Page(s) 1117–1120

    MeSH term(s) Calcium Channel Blockers/therapeutic use ; Congenital Hyperinsulinism/complications ; Congenital Hyperinsulinism/drug therapy ; Diazoxide/therapeutic use ; Female ; Humans ; Hyperinsulinism ; Infant ; Pregnancy
    Chemical Substances Calcium Channel Blockers ; Diazoxide (O5CB12L4FN)
    Language English
    Publishing date 2022-05-27
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1097676-0
    ISSN 1432-5233 ; 0940-5429
    ISSN (online) 1432-5233
    ISSN 0940-5429
    DOI 10.1007/s00592-022-01898-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Case report: Non-PTH-dependent hypercalcemia in pregnancy: Consider CYP24A1 mutations.

    Lemaitre, Madleen / Lionet, Arnaud / Fages, Victor / Vantyghem, Marie-Christine / Subtil, Damien / Vambergue, Anne

    Annales d'endocrinologie

    2023  Volume 84, Issue 6, Page(s) 758–760

    MeSH term(s) Pregnancy ; Female ; Humans ; Hypercalcemia/genetics ; Vitamin D3 24-Hydroxylase/genetics ; Mutation ; Calcium ; Vitamin D
    Chemical Substances Vitamin D3 24-Hydroxylase (EC 1.14.15.16) ; Calcium (SY7Q814VUP) ; Vitamin D (1406-16-2) ; CYP24A1 protein, human (EC 1.14.15.16)
    Language English
    Publishing date 2023-06-13
    Publishing country France
    Document type Case Reports ; Letter
    ZDB-ID 299-9
    ISSN 2213-3941 ; 0003-4266
    ISSN (online) 2213-3941
    ISSN 0003-4266
    DOI 10.1016/j.ando.2023.05.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Pre-gestational diabetes and the risk of congenital heart defects in the offspring: A French nationwide study.

    Lemaitre, Madleen / Bourdon, Gurvan / Bruandet, Amélie / Lenne, Xavier / Subtil, Damien / Rakza, Thameur / Vambergue, Anne

    Diabetes & metabolism

    2023  Volume 49, Issue 4, Page(s) 101446

    Abstract: Aim: To compare the frequencies and types of congenital heart defects for infants of women without and with pre-gestational diabetes, type 1 and type 2 diabetes (T1DM, T2DM) and to identify risk factors.: Methods: All live births between 2012 and ... ...

    Abstract Aim: To compare the frequencies and types of congenital heart defects for infants of women without and with pre-gestational diabetes, type 1 and type 2 diabetes (T1DM, T2DM) and to identify risk factors.
    Methods: All live births between 2012 and 2020 were screened for maternal diabetes and infant congenital heart defects using the French Medical Information System Program in Medicine, Surgery and Obstetrics database (PMSI-MCO). Incidences of these defects were estimated, and a logistic model evaluated maternal and fetal prognostic risk factors.
    Results: Overall, 6,038,703 mothers did not have pre-gestational diabetes (no-diabetes), 23,147 had T1DM, and 14,401 had T2DM. The incidence of infant congenital disease was 6.2% for the no-diabetes group, 8.0%, for women with T1DM, and 8.4% for women with T2DM (P < 0.001); for congenital heart defects, incidences were respectively 0.8%, 3.0% and 2.7% (P < 0.001). In comparison with the no-diabetes group, the odds ratios (95%CI) of coronary heart defects were 2.07 (1.91;2.24) (P < 0.001) for women with T1DM and 2.20 (1.99;2.44) (P < 0.001) for women with T2DM, with no difference between T1DM and T2DM (P = 0.336). cesarian section, small and large for gestational age, and prematurity were also associated with an increased risk of congenital heart defects.
    Conclusion: In this study we observed higher incidences of congenital heart defects in infants of women with pre-gestational diabetes compared to women without pre-gestational diabetes, with no difference between women with T1DM or T2DM. These data call for intensifying preconception care and justify systematic cardiac echography in selected fetuses.
    MeSH term(s) Pregnancy ; Female ; Humans ; Diabetes, Gestational/epidemiology ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 1/complications ; Heart Defects, Congenital/epidemiology ; Heart Defects, Congenital/complications ; Risk Factors
    Language English
    Publishing date 2023-04-07
    Publishing country France
    Document type Journal Article
    ZDB-ID 1315751-6
    ISSN 1878-1780 ; 1262-3636 ; 0338-1684
    ISSN (online) 1878-1780
    ISSN 1262-3636 ; 0338-1684
    DOI 10.1016/j.diabet.2023.101446
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Cross-sectional study examining factors impacting on uptake of postpartum type 2 diabetes screening among women diagnosed with hyperglycaemia in pregnancy.

    Tang, Luveon / Lebreton, Elodie / Vambergue, Anne / Fosse-Edorh, Sandrine / Olié, Valérie / Barry, Yaya / Weill, Alain / Cosson, Emmanuel / Regnault, Nolwenn

    Diabetes research and clinical practice

    2024  Volume 208, Page(s) 111116

    Abstract: Aims: Early postpartum glucose screening of women with hyperglycaemia in pregnancy (HIP) can identify women who have the highest risk of developing impaired glucose tolerance and T2DM. This study examines the association between demographics, events ... ...

    Abstract Aims: Early postpartum glucose screening of women with hyperglycaemia in pregnancy (HIP) can identify women who have the highest risk of developing impaired glucose tolerance and T2DM. This study examines the association between demographics, events during pregnancy, socioeconomic status and postpartum T2DM screening.
    Methods: Using the French National Health Data System, this cross-sectional study included all deliveries where the mother had HIP in France in 2015, (n = 76,862). The odds ratio (OR) for attending postpartum screening was calculated via multi-level logistic regression.
    Results: T2DM screening uptake at six months postpartum was 42·9% [95 % Confidence Interval: 42·6-43·3]. Several characteristics were associated with lower uptake: living in the most deprived area(OR = 0·78[0·74-0·83]); being < 25 years-old (reference age group 25-29;≤17: 0.53 [0·31-0·90];18-24: 0.73[0·69-0·78]); smoking (0·65[0·62-0·68]); obesity (0·93[0·89-0·97]); caesarean delivery (0·95[0·92-0·99]). Factors associated with higher uptake included primiparity (1·30[1·26-1·34]); having followed the French recommendations for HIP screening (1·24[1·20-1·28]); insulin prescription (1·75[1·69-1·81]) and pre-eclampsia (1·30[1·19-1·42]). p < 0.01 is justified due to sample size.
    Conclusion: Improving identification of factors affecting postpartum T2DM screening uptake, such as demographics, socioeconomic context and events during pregnancy, may lead to development of target interventions to aide adherence to screening regime and thereby diagnosis of women with prediabetes or diabetes, for whom secondary and tertiary prevention is crucial.
    MeSH term(s) Pregnancy ; Female ; Humans ; Adult ; Hyperglycemia/diagnosis ; Hyperglycemia/epidemiology ; Diabetes Mellitus, Type 2/diagnosis ; Diabetes Mellitus, Type 2/epidemiology ; Cross-Sectional Studies ; Diabetes, Gestational/diagnosis ; Diabetes, Gestational/epidemiology ; Glucose Tolerance Test ; Postpartum Period
    Language English
    Publishing date 2024-01-23
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 632523-3
    ISSN 1872-8227 ; 0168-8227
    ISSN (online) 1872-8227
    ISSN 0168-8227
    DOI 10.1016/j.diabres.2024.111116
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Intermittently scanned continuous glucose monitoring is associated with lower spontaneous abortion rate compared with conventional blood glucose monitoring in pregnant women with type 1 diabetes: An observational study.

    Lemaitre, Madleen / Faiz, Kenza / Baudoux, Florence / Subtil, Damien / Vambergue, Anne

    Diabetes & vascular disease research

    2022  Volume 19, Issue 6, Page(s) 14791641221136837

    Abstract: Aim: The objective of the present real-life study in France was to assess and compare characteristics and outcomes in a cohort of pregnant women with type 1 diabetes (T1D) using intermittently scanned continuous glucose monitoring (isCGM) or ... ...

    Abstract Aim: The objective of the present real-life study in France was to assess and compare characteristics and outcomes in a cohort of pregnant women with type 1 diabetes (T1D) using intermittently scanned continuous glucose monitoring (isCGM) or conventional blood glucose monitoring (BGM).
    Material and methods: We performed an observational study of a cohort of 153 women with T1D: 77 women were using isCGM, and 76 were using BGM. We compared the groups' maternal characteristics and maternal-fetal complications. The level of HbA1c was measured before pregnancy and then four times (after 8-12, 24-28, 30-33, and 35-37 weeks of gestation).
    Results: The two groups were similar in terms of age, prepregnancy BMI, diabetes duration, and diabetic vascular complications. There were no significant intergroup differences in the obstetric history. The spontaneous abortion rate was lower in the isCGM group than in the blood glucose monitoring group (5.3% vs. 20%, respectively;
    Conclusions: This observational study demonstrates that isCGM use is associated with lower spontaneous abortion compared with conventional BGM. Large prospective studies are needed to corroborate our findings and fully understand the relationship between glucose data at the time of conception/early pregnancy and foetal outcome.
    MeSH term(s) Female ; Humans ; Pregnancy ; Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 1/diagnosis ; Blood Glucose Self-Monitoring ; Blood Glucose ; Glycated Hemoglobin ; Abortion, Spontaneous/diagnosis ; Abortion, Spontaneous/etiology ; Pregnant Women ; Hypoglycemic Agents
    Chemical Substances Blood Glucose ; Glycated Hemoglobin ; Hypoglycemic Agents
    Language English
    Publishing date 2022-12-14
    Publishing country England
    Document type Observational Study ; Journal Article
    ZDB-ID 2250793-0
    ISSN 1752-8984 ; 1479-1641
    ISSN (online) 1752-8984
    ISSN 1479-1641
    DOI 10.1177/14791641221136837
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Le diabète gestationnel : diagnostic et prise en charge à court et à long terme.

    Vambergue, Anne

    Presse medicale (Paris, France : 1983)

    2013  Volume 42, Issue 5, Page(s) 893–899

    Abstract: Universal consensus on the diagnosis methods and thresholds has long been lacking. The recently published Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study has been used to confirm the link between hyperglycemia and materno-fetal complications. ... ...

    Title translation Gestational diabetes: diagnosis, short and long term management.
    Abstract Universal consensus on the diagnosis methods and thresholds has long been lacking. The recently published Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study has been used to confirm the link between hyperglycemia and materno-fetal complications. Consequently, in France, the Société francophone du diabète (SFD) and the Collège national des gynécologues et obstétriciens français (CNGOF) proposed an expert consensus on gestational diabetes mellitus for clinical practice. Fasting blood glucose should be measured at the first visit during early pregnancy for women with risk factors to identify the women with pregestational diabetes. It is proposed a selective screening on risk factors rather than universal screening. Specific treatment of gestational diabetes reduced materno-fetal complications compared to the absence of therapy. Women with a history of gestational diabetes mellitus are characterized by a high risk of type 2 diabetes mellitus.
    MeSH term(s) Blood Glucose/analysis ; Combined Modality Therapy ; Contraindications ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes, Gestational/diagnosis ; Diabetes, Gestational/epidemiology ; Diabetes, Gestational/therapy ; Diet, Diabetic ; Disease Management ; Disease Progression ; Early Diagnosis ; Exercise ; Expert Testimony ; Female ; Glucose Tolerance Test ; Humans ; Hypoglycemic Agents/therapeutic use ; Infant, Newborn ; Metabolic Syndrome/embryology ; Metabolic Syndrome/epidemiology ; Practice Guidelines as Topic ; Pregnancy ; Pregnancy Complications/epidemiology ; Pregnancy Complications/prevention & control ; Prenatal Diagnosis ; Prenatal Exposure Delayed Effects ; Risk Factors
    Chemical Substances Blood Glucose ; Hypoglycemic Agents
    Language French
    Publishing date 2013-05
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 120943-7
    ISSN 2213-0276 ; 0032-7867 ; 0755-4982 ; 0301-1518
    ISSN (online) 2213-0276
    ISSN 0032-7867 ; 0755-4982 ; 0301-1518
    DOI 10.1016/j.lpm.2013.02.316
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Is the Development of Gestational Diabetes Associated With the ABO Blood Group/Rhesus Phenotype?

    Lemaitre, M / Passet, M / Ghesquière, L / Martin, C / Drumez, E / Subtil, D / Vambergue, A

    Frontiers in endocrinology

    2022  Volume 13, Page(s) 916903

    Abstract: Aims: There are few published data on the putative association between the ABO blood group/rhesus (Rh) factor and the risk of developing gestational diabetes mellitus (GDM). Our aim was to explore the link between each one factor and GDM development.: ...

    Abstract Aims: There are few published data on the putative association between the ABO blood group/rhesus (Rh) factor and the risk of developing gestational diabetes mellitus (GDM). Our aim was to explore the link between each one factor and GDM development.
    Methods: All women having given birth at Lille University Medical Center (Lille, France) between August 1
    Results: 1194 women had at least one GDM risk factor. The percentage of GDM varied with the ABO group (p=0.013). Relative to group O women, group AB women were more likely to develop GDM (OR = 2.50, 95% CI [1.43 to 4.36], p=0.001). Compared with the Rh-positive O group, only the Rh-positive AB group had an elevated risk of developing GDM (OR = 3.02, 95% CI [1.69 to 5.39], p < 0.001).
    Conclusions: Our results showed that Rh-positive group AB women have a greater risk of GDM. With a view to preventing GDM, at-risk individuals could be identified by considering the ABO blood group phenotype either as a single risk factor or in combination with other risk factors.
    MeSH term(s) ABO Blood-Group System ; Diabetes, Gestational ; Female ; Humans ; Logistic Models ; Phenotype ; Pregnancy ; Risk Factors
    Chemical Substances ABO Blood-Group System
    Language English
    Publishing date 2022-06-22
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2022.916903
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Expert consensus on gestational diabetes mellitus.

    Vambergue, A

    Diabetes & metabolism

    2010  Volume 36, Issue 6 Pt 2, Page(s) 511

    MeSH term(s) Consensus Development Conferences as Topic ; Diabetes, Gestational/diagnosis ; Female ; France ; Humans ; Mass Screening/standards ; Pregnancy
    Language English
    Publishing date 2010-12
    Publishing country France
    Document type Editorial
    ZDB-ID 1315751-6
    ISSN 1878-1780 ; 1262-3636 ; 0338-1684
    ISSN (online) 1878-1780
    ISSN 1262-3636 ; 0338-1684
    DOI 10.1016/j.diabet.2010.11.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The impact of lockdown on maternal and neonatal morbidity in gestational diabetes mellitus.

    Tollini, Valentine / Lemaître, Madleen / Garabedian, Charles / Martin, Claire / Bengler, Cyril / Vambergue, Anne / Ghesquière, Louise

    American journal of obstetrics and gynecology

    2022  Volume 227, Issue 5, Page(s) 775–777

    Language English
    Publishing date 2022-06-25
    Publishing country United States
    Document type Letter
    ZDB-ID 80016-8
    ISSN 1097-6868 ; 0002-9378
    ISSN (online) 1097-6868
    ISSN 0002-9378
    DOI 10.1016/j.ajog.2022.06.033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Implementation of a clinical decision support system for the optimization of antidiabetic drug orders by pharmacists.

    Robert, Laurine / Quindroit, Paul / Henry, Héloïse / Perez, Maxime / Rousselière, Chloé / Lemaitre, Madleen / Vambergue, Anne / Décaudin, Bertrand / Beuscart, Jean-Baptiste

    British journal of clinical pharmacology

    2023  Volume 90, Issue 1, Page(s) 239–246

    Abstract: Aims: The objective of the study was to describe the impact of a clinical decision support system (CDSS) on antidiabetic drug management by clinical pharmacists for hospitalized patients with T2DM.: Methods: We performed a retrospective, single- ... ...

    Abstract Aims: The objective of the study was to describe the impact of a clinical decision support system (CDSS) on antidiabetic drug management by clinical pharmacists for hospitalized patients with T2DM.
    Methods: We performed a retrospective, single-centre study in a teaching hospital, where clinical pharmacists analysed prescriptions and issued pharmacist interventions (PIs) through a computerized physician order entry (CPOE) system. A CDSS was integrated into the pharmacists' workflow in July 2019. We analysed PIs during 2 periods of interest: one before the introduction of the CDSS (from November 2018 to April 2019, PIs issued through the CPOE alone) and one afterwards (from November 2020 to April 2021, PIs issued through the CPOE and/or the CDSS). The study covered nondiabetology wards as endocrinology, diabetes and metabolism departments were not computerized at the time of the study.
    Results: There were 203 PIs related to antidiabetic drugs in period 1 and 319 in period 2 (a 57.5% increase). Sixty-four of the 319 PIs were generated by the CDSS. Noncompliance/contraindication was the main problem identified by the CDSS (41 PIs, 68.4%), and 57.8% led to discontinuation of the drug. Most of the PIs issued through the CDSS corresponded to orders that had not been flagged up by clinical pharmacists using the CPOE. Conversely, most alerts about indications that were not being treated were detected by the clinical pharmacists using the CPOE and not by the CDSS.
    Conclusion: Use of CDSS by clinical pharmacists improved antidiabetic drug management for hospitalized patients with T2DM. The CDSS might add value to diabetes care in nondiabetology wards by decreasing the frequency of potentially inappropriate prescriptions and adverse drug reactions.
    MeSH term(s) Humans ; Pharmacists ; Decision Support Systems, Clinical ; Hypoglycemic Agents/adverse effects ; Retrospective Studies ; Pharmacy Service, Hospital ; Diabetes Mellitus, Type 2/drug therapy
    Chemical Substances Hypoglycemic Agents
    Language English
    Publishing date 2023-09-15
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 188974-6
    ISSN 1365-2125 ; 0306-5251 ; 0264-3774
    ISSN (online) 1365-2125
    ISSN 0306-5251 ; 0264-3774
    DOI 10.1111/bcp.15898
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top